Team approach to polypharmacy evaluation and reduction for general practice patients with dementia: the Australian TAPERDem study.
- DOI
- 10.1177/20420986261464335
- Published
- 2026
- Container
- Therapeutic advances in drug safety
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/20420986261464335,
title = {Team approach to polypharmacy evaluation and reduction for general practice patients with dementia: the Australian TAPERDem study.},
author = {Etherton-Beer C and Page AT and Quek HW and Parkinson L and Naganathan V and Caughey G and Redfern J and Clifford R and Hilmer S and Mangin D},
year = {2026},
journal = {Therapeutic advances in drug safety},
doi = {10.1177/20420986261464335},
url = {https://doi.org/10.1177/20420986261464335}
}RIS
TY - JOUR TI - Team approach to polypharmacy evaluation and reduction for general practice patients with dementia: the Australian TAPERDem study. AU - Etherton-Beer C AU - Page AT AU - Quek HW AU - Parkinson L AU - Naganathan V AU - Caughey G AU - Redfern J AU - Clifford R AU - Hilmer S AU - Mangin D PY - 2026 JO - Therapeutic advances in drug safety DO - 10.1177/20420986261464335 UR - https://doi.org/10.1177/20420986261464335 ER -
APA
C, E., AT, P., HW, Q., L, P., V, N., G, C., J, R., R, C., S, H., & D, M. (2026). Team approach to polypharmacy evaluation and reduction for general practice patients with dementia: the Australian TAPERDem study.. Therapeutic advances in drug safety. https://doi.org/10.1177/20420986261464335
Source records
- pubmed · retrieved 2026-09-25T16:24:59.871Z